Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ

Details Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ

1996-08-07

1997-12-30

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 31495

Patent

active

057030774

ABSTRACT:
A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof and mixtures thereof, wherein R.sub.1 and R.sub.2 each is selected from the group consisting of alkyl radicals containing 1 to 4 carbon atoms and alkoxy radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R.sub.3, R.sub.4 and R.sub.5 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is independently selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms wherein the desired therapeutic effect is an increase in renal fluid flow.

REFERENCES:
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4188393 (1980-02-01), Neuman
patent: 4656291 (1987-04-01), Maryanoff et al.
patent: 5021416 (1991-06-01), Gluchowski
patent: 5034406 (1991-07-01), Gluchowski
patent: 5077292 (1991-12-01), Gluchowski
patent: 5112822 (1992-05-01), Gluchowski
patent: 5130441 (1992-07-01), Gluchowski
patent: 5198442 (1993-03-01), Gluchowski
patent: 5204347 (1993-04-01), Gluchowski
patent: 5231096 (1993-07-01), Gluchowski
patent: 5237072 (1993-08-01), Gluchowski
Williams et al, J. Auton, Pharmacol., 10 (4):247, Aug. 1990 Abstract.
Fondacaro et al, Am. Soc. for Pharm., V 247, 1987, 481-486.
Scrip Product Information, Scrip No. 1466, pp. 28, Nov. 1989.
Chemical Abstracts, vol. 98, 98:921X, 1983.
Chemical Abstracts, 91:168403M, 1979.
Walland, Chemical Abstracts, vol. 88, No. 23, p. 80, 1978.
Philippu et al, Chemical Abstracts, vol. 99, No. 15, p. 137, 1983.
Ekas et al, Chemical Abstrcts, vol. 98:210440t (1983).
Steppler et al, Chemical Abstracts, vol. 91, No. 21, p. 43, 1979.
Steppler et al, Chemical Abstracts, vol. 90, No. 5, p. 37, 1979.
Timmermans et al, Chemical Abstracts: 89:474V, 1978.
Boudier et al, Chemical Abstracts, vol. 82, No. 17, p. 13, 1975.
Burke et al, Current Eye Research, Sep. 5(9): 665-76, 1986.
Mittag, Annals of Opthalmology, 15(3), 201-202, 1983.
Fielding, Medicinal Research Reviews, vol. 1, No. 1, pp. 97-123, 1981.
Isom et al, The Fournal of Biological Chemistry, vol. 262, No. 14, pp. 6750-6757, May 1987.
Timmermans Eur. J. Med. Chem., 15(4), pp. 323-329, 1980.
Langer et al, Journal of Cardiovascular Pharm., vol. 7, Supp. 8 (S1-S8) 1985.
Nielsen et al, Br. J. Pharmacol, 97 (834), 1989.
B. Bloor, Seminars in Anesthesia, vol. KVII, No. 3, pp. 170-177, Sep. 1988.
Sato et al, Sciene, vol. 251, p. 1608-1610, Mar. 1991.
Gellai et al, The Journal of Pharmacology & Exp. Therap., 240(3), pp. 723-728, 1987.
Jarrot, Hardbook of Hypertension, vol. 5, 113-168 (198).
Bloor et al, Anesthesia & Analgesia, vol. 61, No. 9, 741-745, Sep. 1982.
VanZwieten et al, Advances in Drug Research, vol. 13, 209-254, 1984.
Dharmsathaphorn, Gastroenterology, 91(3), 769-70, 1986.
Jumblatt et al, Current Eye Research, vol. 6, pp. 767-777, 1987.
Fondacaro et al, American Society for Pharmacology, vol. 247, 1987, pp. 481-486.
Bendele et al, Pharmacol, 82, pp. 152, Aug. 1991 (Abstract).
Hieble et al, The Pharmacol, 82, pp. 152, Aug. 1991.
Goodman Gilman et al, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 8, pp. 174-179, 1985.
Berridge et al, Br. J. Pharmac., 88(2), 345-354, 1986.
Thaina et al, J. Autonomic Pharmacology, 13(2), 95-176, 1993.
Hayes et al, Neuropharmacology, 25(4), 391-396, 1986.
Gellai et al, Am. Physio. Soc., F317-323, 1988.
Colpaert, F.C., Drug Development Research, 7:209-220, 1986.
Colpaert, F., Drug Development Research, 7(3), 209-220, 1986 (Abstract).
Dharmsathaphorn et al, Gastroenterology, 86(1), 120-128, 1984.
Contiello et al, J. Biol. Chem., 264 (27), pp. 16000-16007, 1989.
Thaina et al, J. Auton Pharmacol, vol., 3 No. 2, pp. 115-126, Apr. 1993.
Hayes et al, Neuropharmacology, vol. 25, pp. 391-396, 1986.
Wiliams et al, J. Auton Pharmacol, 10(4):247, Aug. 1990 (Abstract).
Hildebrand, J. Pharmacol Exp. Ther., 263(2) pp. 510-519, Nov. 1992 (Abstract).
Fondacaro, J. Pharmacol Exp. Ther., 247(2), pp. 481-486, Jul. 1988.
Smyth et al., The Journal of Pharmacology and Therapeutics, V. 251, No. 3 1992, pp. 1080-1086.

Affiliated with

Also associated with

Rating

Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for using (2-imidazolin-2-ylamino) quinoxaline derivativ will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-202455